Literature DB >> 6331649

Characterization of monoclonal antibodies directed against the envelope proteins of feline leukemia virus.

S D Youngren, A P Vukasin, F de Noronha.   

Abstract

Monoclonal antibodies directed against the feline leukemia virus (FeLV) envelope proteins, gp70 and p15E, were identified by radioimmunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Six of these monoclonal antibodies were specific for the gp70; two for the p15E. Enzyme-linked immunosorbent assay binding assays against FeLV subtypes A, B, and C showed that most of the monoclonal antibodies bound to more than one subtype but have a greater affinity for subtype B. One monoclonal bound exclusively to the FL74 isolate. These studies also indicate that antigenic variability exists between FeLV isolates previously classified as being the same subtype. One antibody was found to bind the gp70s of all FeLV isolates tested and to be directed against a viral neutralizing site. A p15E-specific monoclonal antibody, in addition to binding all the FeLV subtypes, also bound to Moloney and Rauscher murine leukemia viruses, suggesting a group determinant is involved. No binding was seen to human T-cell leukemia virus, bovine leukemia virus, equine infectious anemia virus, or RD114V proteins, however.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331649

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.

Authors:  T J Palker; T J Matthews; M E Clark; G J Cianciolo; R R Randall; A J Langlois; G C White; B Safai; R Snyderman; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 2.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.